Biomea Fusion, Inc. (BMEA)
1.44
+0.07
(+5.11%)
USD |
NASDAQ |
Oct 09, 15:03
Biomea Fusion Total Return Level : 1.37 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.37 |
| October 07, 2026 | 1.32 |
| October 06, 2026 | 1.25 |
| October 05, 2026 | 1.30 |
| October 02, 2026 | 1.27 |
| October 01, 2026 | 1.30 |
| September 30, 2026 | 1.33 |
| September 29, 2026 | 1.26 |
| September 28, 2026 | 1.29 |
| September 25, 2026 | 1.32 |
| September 24, 2026 | 1.49 |
| September 23, 2026 | 1.44 |
| September 22, 2026 | 1.70 |
| September 21, 2026 | 1.71 |
| September 18, 2026 | 1.83 |
| September 17, 2026 | 1.79 |
| September 16, 2026 | 1.74 |
| September 15, 2026 | 1.80 |
| September 14, 2026 | 1.78 |
| September 11, 2026 | 1.74 |
| September 10, 2026 | 1.70 |
| September 09, 2026 | 1.845 |
| September 08, 2026 | 1.93 |
| September 04, 2026 | 2.03 |
| September 03, 2026 | 1.91 |
| Date | Value |
|---|---|
| September 02, 2026 | 1.935 |
| September 01, 2026 | 1.80 |
| August 31, 2026 | 1.68 |
| August 28, 2026 | 1.73 |
| August 27, 2026 | 1.68 |
| August 26, 2026 | 1.71 |
| August 25, 2026 | 1.73 |
| August 24, 2026 | 1.59 |
| August 21, 2026 | 1.37 |
| August 20, 2026 | 1.36 |
| August 19, 2026 | 1.39 |
| August 18, 2026 | 1.35 |
| August 17, 2026 | 1.35 |
| August 14, 2026 | 1.32 |
| August 13, 2026 | 1.28 |
| August 12, 2026 | 1.28 |
| August 11, 2026 | 1.29 |
| August 10, 2026 | 1.27 |
| August 07, 2026 | 1.26 |
| August 06, 2026 | 1.25 |
| August 05, 2026 | 1.26 |
| August 04, 2026 | 1.23 |
| August 03, 2026 | 1.20 |
| July 31, 2026 | 1.17 |
| July 30, 2026 | 1.22 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| REGENXBIO, Inc. | 8.09 |
| Compass Therapeutics, Inc. | 0.9834 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |
| Savara, Inc. | 4.83 |